These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 6155067

  • 21. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
    Davidson D, Pullar IA, Mawdsley C, Kinloch N, Yates CM.
    J Neurol Neurosurg Psychiatry; 1977 Aug; 40(8):741-5. PubMed ID: 925693
    [Abstract] [Full Text] [Related]

  • 22. CSF monoamine metabolites in schizophrenic patients.
    Gattaz WF, Waldmeier P, Beckmann H.
    Acta Psychiatr Scand; 1982 Nov; 66(5):350-60. PubMed ID: 6184954
    [Abstract] [Full Text] [Related]

  • 23. Amine metabolites in ventricular cerebrospinal fluid in coma.
    Yates CM, Tsementzis SA, Wilson H.
    J Neurol Neurosurg Psychiatry; 1979 Oct; 42(10):887-91. PubMed ID: 512664
    [Abstract] [Full Text] [Related]

  • 24. Monoamine metabolite levels in cerebrospinal fluid and brain atrophy in lobotomized schizophrenic patients.
    Rimón R, Roos BE, Kampman R, Hyyppä S, Ranta P, Myllylä V.
    Ann Clin Res; 1979 Feb; 11(1):25-9. PubMed ID: 453776
    [Abstract] [Full Text] [Related]

  • 25. CSF monamine metabolites in movement disorders and normal aging.
    Stahl SM, Faull KF, Barchas JD, Berger PA.
    Arch Neurol; 1985 Feb; 42(2):166-9. PubMed ID: 2579626
    [Abstract] [Full Text] [Related]

  • 26. Monoamine metabolites in successive samples of spinal fluid. A comparison between healthy volunteers and patients with multiple sclerosis.
    Andersen O, Johansson BB, Svennerholm L.
    Acta Neurol Scand; 1981 Apr; 63(4):247-54. PubMed ID: 6163303
    [Abstract] [Full Text] [Related]

  • 27. Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients.
    Sedvall GC, Wode-Helgodt B.
    Arch Gen Psychiatry; 1980 Oct; 37(10):1113-6. PubMed ID: 6158928
    [Abstract] [Full Text] [Related]

  • 28. Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects.
    Thorén P, Asberg M, Bertilsson L, Mellström B, Sjöqvist F, Träskman L.
    Arch Gen Psychiatry; 1980 Nov; 37(11):1289-94. PubMed ID: 6159865
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard.
    Javors MA, Bowden CL, Maas JW.
    J Chromatogr; 1984 Dec 12; 336(2):259-69. PubMed ID: 6085084
    [Abstract] [Full Text] [Related]

  • 33. CSF monoamine metabolites in mania.
    Swann AC, Secunda S, Davis JM, Robins E, Hanin I, Koslow SH, Maas JW.
    Am J Psychiatry; 1983 Apr 12; 140(4):396-400. PubMed ID: 6188381
    [Abstract] [Full Text] [Related]

  • 34. Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection.
    Scheinin M, Chang WH, Kirk KL, Linnoila M.
    Anal Biochem; 1983 May 12; 131(1):246-53. PubMed ID: 6193730
    [Abstract] [Full Text] [Related]

  • 35. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs.
    Sedvall G.
    Prog Biochem Pharmacol; 1980 May 12; 16():133-40. PubMed ID: 6160594
    [Abstract] [Full Text] [Related]

  • 36. Developmental variations in CSF monoamine metabolites during childhood.
    Hedner J, Lundell KH, Breese GR, Mueller RA, Hedner T.
    Biol Neonate; 1986 May 12; 49(4):190-7. PubMed ID: 2423144
    [Abstract] [Full Text] [Related]

  • 37. Cerebrospinal fluid concentration of biogenic amine metabolites in idiopathic apnea of prematurity.
    Bhat AM, Scanlon JW, Lavenstein B, Chuang L, Karoum F.
    Biol Neonate; 1983 May 12; 43(1-2):16-22. PubMed ID: 6850011
    [Abstract] [Full Text] [Related]

  • 38. The effects of amiflamine on cerebrospinal fluid amine metabolites in the rhesus monkey.
    Garrick NA, Seppala T, Linnoila M, Murphy DL.
    Eur J Pharmacol; 1985 Mar 26; 110(1):1-9. PubMed ID: 2408906
    [Abstract] [Full Text] [Related]

  • 39. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S.
    Biol Psychiatry; 1983 Oct 26; 18(10):1141-52. PubMed ID: 6197099
    [Abstract] [Full Text] [Related]

  • 40. CSF monoamine metabolites in melancholia.
    Asberg M, Bertilsson L, Mårtensson B, Scalia-Tomba GP, Thorén P, Träskman-Bendz L.
    Acta Psychiatr Scand; 1984 Mar 26; 69(3):201-19. PubMed ID: 6201041
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.